FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

N. Newsome, Philip; Sasso, M.; J Deeks, Jonathan; H. Paredes, Angelo; Boursier, Jérôme; Chan, Wah‐Kheong; Yılmaz, Yusuf; Czernichow, Sébastien; Zheng, Ming‐Hua; Wai‐Sun Wong, Vincent; Allison, Michael; Tsochatzis, Emmanuel; M. Anstee, Quentin; Sheridan, David; Eddowes, Peter; Neil Guha, Indra; Cobbold, Jeremy; Paradis, Valérie; Bédossa, Pierre; Miette, Véronique; Fournier‐Poizat, Céline; Sandrin, Laurent; Harrison, Stephen

doi:10.1016/s2468-1253(19)30383-8

Public

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

Published in The Lancet. Gastroenterology & hepatology • Feb 3, 2020

Authors:

Philip N. Newsome

M. Sasso

Jonathan J Deeks

Abstract

BACKGROUND: The burden of non-alcoholic fatty liver disease (NAFLD) is increasing globally, and a major priority is to identify patients with non-alcoholic steatohepatitis (NASH) who are at greater risk of progression to cirrhosis, and who will be candidates for clinical trials and emerging new phar...

Subject

Medicine

Transient elastography

Steatohepatitis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!